IQVIA Holdings Inc. (LON:0JDM)

London flag London · Delayed Price · Currency is GBP · Price in USD
231.30
+2.29 (1.00%)
At close: Nov 28, 2025
14.37%
Market Cap29.59B
Revenue (ttm)11.83B
Net Income (ttm)954.48M
Shares Outn/a
EPS (ttm)5.43
PE Ratio31.00
Forward PE18.18
Dividendn/a
Ex-Dividend Daten/a
Volume60
Average Volume542
Open233.43
Previous Close229.01
Day's Range229.99 - 233.43
52-Week Range134.83 - 234.42
Betan/a
RSI66.04
Earnings DateFeb 6, 2026

About IQVIA Holdings

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
CEO Ari Bousbib
Employees 88,000
Stock Exchange London Stock Exchange
Ticker Symbol 0JDM
Full Company Profile

Financial Performance

In 2024, IQVIA Holdings's revenue was $15.41 billion, an increase of 2.81% compared to the previous year's $14.98 billion. Earnings were $1.37 billion, an increase of 1.10%.

Financial numbers in USD Financial Statements

News

BMO Capital Initiates Coverage on IQVIA Holdings (IQV) with Outperform Rating | IQV Stock News

BMO Capital Initiates Coverage on IQVIA Holdings (IQV) with Outperform Rating | IQV Stock News

16 days ago - GuruFocus

Oakmark Global Concentrated Strategy Q3 2025 Top Contributors And Detractors

Alibaba Group was a contributor during the quarter. The stock price rose significantly following earnings that reflected rapid Chinese AI growth. Alphabet was a contributor during the quarter. The sto...

17 days ago - Seeking Alpha

Oakmark Concentrated Strategy: 6 Stocks That Raised Guidance And Drove Innovation

Warner Bros Discovery reported merger with Paramount-Skydance could generate meaningful cost synergies and create a scaled competitor with a deep and unmatched content library. Innovations in the Goog...

22 days ago - Seeking Alpha

IQVIA Holdings Inc. (IQV) Appoints Dr. William G. Kaelin Jr. to Board of Directors

IQVIA Holdings Inc. (IQV) Appoints Dr. William G. Kaelin Jr. to Board of Directors

23 days ago - GuruFocus

Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of ...

24 days ago - Business Wire

IQV Stock Downgraded: Analyst Rating Update and Price Target Raised | IQV Stock News

IQV Stock Downgraded: Analyst Rating Update and Price Target Raised | IQV Stock News

26 days ago - GuruFocus

IQVIA Holdings Inc (IQV) Q3 2025 Earnings Call Highlights: Record Free Cash Flow and Strong ...

IQVIA Holdings Inc (IQV) Q3 2025 Earnings Call Highlights: Record Free Cash Flow and Strong Backlog Growth

4 weeks ago - GuruFocus

Citigroup Raises IQVIA (IQV) Price Target Amid Neutral Rating | IQV Stock News

Citigroup Raises IQVIA (IQV) Price Target Amid Neutral Rating | IQV Stock News

4 weeks ago - GuruFocus

IQV: UBS Raises Price Target to $250, Maintains Buy Rating | IQV Stock News

IQV: UBS Raises Price Target to $250, Maintains Buy Rating | IQV Stock News

4 weeks ago - GuruFocus

Stifel Raises Price Target for IQVIA Holdings (IQV) to $254, Maintains Buy Rating | IQV Stock News

Stifel Raises Price Target for IQVIA Holdings (IQV) to $254, Maintains Buy Rating | IQV Stock News

4 weeks ago - GuruFocus

IQV: Truist Securities Raises Price Target for IQVIA Holdings | IQV Stock News

IQV: Truist Securities Raises Price Target for IQVIA Holdings | IQV Stock News

4 weeks ago - GuruFocus

IQVIA (IQV): JP Morgan Raises Price Target to $255, Maintains Overweight Rating | IQV Stock News

IQVIA (IQV): JP Morgan Raises Price Target to $255, Maintains Overweight Rating | IQV Stock News

4 weeks ago - GuruFocus

IQV: Baird Upgrades and Raises Price Target to $258 | IQV Stock News

IQV: Baird Upgrades and Raises Price Target to $258 | IQV Stock News

4 weeks ago - GuruFocus

IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare ...

4 weeks ago - Nasdaq

IQVIA (IQV) Reports Record Free Cash Flow in Q3 2025

IQVIA (IQV) Reports Record Free Cash Flow in Q3 2025

4 weeks ago - GuruFocus

IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript

IQVIA Holdings Inc. (NYSE:IQV) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDT Company Participants Kerri Joseph - SVP of Investment Relation & Treasury Ari Bousbib - CEO & Chairman Ronald Bruehlm...

4 weeks ago - Seeking Alpha

IQVIA Holdings Inc. 2025 Q3 - Results - Earnings Call Presentation

2025-10-28. The following slide deck was published by IQVIA Holdings Inc.

4 weeks ago - Seeking Alpha

IQVIA Holdings Inc (IQV) Q3 2025 Earnings: EPS of $1. ...

IQVIA Holdings Inc (IQV) Q3 2025 Earnings: EPS of $1.93 Beats Estimate, Revenue Hits $4,100 Million Surpassing Expectations

4 weeks ago - GuruFocus

IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates

IQVIA (IQV) delivered earnings and revenue surprises of +1.35% and +0.86%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

4 weeks ago - Nasdaq

IQVIA narrows annual profit forecast amid continued research contract cancellations

IQVIA Holdings on Tuesday narrowed its annual profit forecast, trimming the upper end of its outlook, as it expects cancellations of research contracts from pharmaceutical clients to persist into the ...

4 weeks ago - Reuters

Earnings Scheduled For October 28, 2025

Companies Reporting Before The Bell • PayPal Holdings (NASDAQ: PYPL) is expected to report quarterly earnings at $1.20 per share on revenue of $8.24 billion. • NeoGenomics (NASDAQ: NEO) is projected...

4 weeks ago - Benzinga

IQVIA Holdings Inc. Q3 Profit Increases, Beats Estimates

(RTTNews) - IQVIA Holdings Inc. (IQV) reported earnings for its third quarter that Increased from last year and beat the Street estimates.

4 weeks ago - Nasdaq

IQVIA Reports Third-Quarter 2025 Results

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the...

4 weeks ago - Business Wire

Smart Acquisitions And Profit Margin Growth Amid Strategic Repositioning

We purchased several new fund holdings across various sectors. Sempra has been shifting its strategic focus from its highly regulated California operations to its growing presence in Texas. Regeneron ...

5 weeks ago - Seeking Alpha